Identification of a human immunodeficiency virus type 1 TAR binding protein in human hepatoblastoma HepG2 cells that trans-activates HIV-1 LTR-directed gene expression

DNA Cell Biol. 1994 Jan;13(1):67-74. doi: 10.1089/dna.1994.13.67.

Abstract

Recently, we have shown that the human immunodeficiency virus (HIV-1) long terminal repeat (LTR) directed chloramphenicol acetyltransferase (CAT) gene is efficiently expressed in human hepatoblastoma HepG2 cells and these cells can support productive HIV-1 replication. In this study we show that HepG2 cells contain a nuclear factor that binds to the HIV-1 trans-activating region (TAR), which we named HepG2-derived TAR binding protein (HTBP). Gel retardation assays using synthetic oligonucleotide probes carrying different mutations in the TAR region and competition DNA mobility-shift experiments using these oligonucleotides revealed the binding site encompassing between +7 and +13 nucleotides (5'-TCTGGTT-3') in the HIV-1 LTR. An in vivo CAT competition assay using -65HIV-1 LTR CAT as a reporter plasmid and various competitor plasmids containing these mutated oligonucleotides also demonstrated that HTBP can influence the HIV-1 LTR-directed CAT gene expression in HepG2 cells by interaction with a specific sequence in the TAR region.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / microbiology
  • DNA-Binding Proteins / metabolism*
  • Gene Expression Regulation, Viral*
  • HIV Long Terminal Repeat / genetics*
  • Humans
  • Liver Neoplasms / genetics
  • Liver Neoplasms / microbiology
  • Molecular Sequence Data
  • Nuclear Proteins / metabolism*
  • RNA, Messenger / genetics
  • Regulatory Sequences, Nucleic Acid
  • Trans-Activators*
  • Transcription, Genetic
  • Transcriptional Activation
  • Tumor Cells, Cultured

Substances

  • DNA-Binding Proteins
  • Nuclear Proteins
  • RNA, Messenger
  • Trans-Activators